Predicted probabilities of brain injury after carbon ion radiotherapy for head and neck and skull base tumors in long-term survivors

被引:4
作者
Park, SungChul [1 ]
Demizu, Yusuke [1 ,2 ]
Suga, Masaki [3 ]
Taniguchi, Shingo [4 ]
Tanaka, Shinichi [4 ]
Maehata, Itsumi [4 ]
Takeda, Mikuni [4 ]
Takahashi, Daiki [1 ]
Matsuo, Yoshiro [1 ]
Sulaiman, Nor Shazrina [1 ]
Terashima, Kazuki [1 ]
Tokumaru, Sunao [1 ]
Furukawa, Kyoji [5 ]
Okimoto, Tomoaki [1 ]
机构
[1] Hyogo Ion Beam Med Ctr, Dept Radiol, 1-2-1 Kouto,Shingu Cho, Tatsuno, Hyogo 6795165, Japan
[2] Hyogo Ion Beam Med Ctr, Kobe Proton Ctr, Dept Radiat Oncol, Tatsuno, Japan
[3] Hyogo Ion Beam Med Ctr, Dept Radiat Phys, Tatsuno, Japan
[4] Hyogo Ion Beam Med Ctr, Dept Radiat Technol, Tatsuno, Japan
[5] Kurume Univ, Biostat Ctr, Grad Sch Med, Fukuoka, Japan
关键词
Carbon ion radiotherapy; Head and neck cancers; Radiation-induced brain injury; Relative biological effectiveness; Skull base tumors; TEMPORAL-LOBE REACTIONS; CENTRAL-NERVOUS-SYSTEM; RADIATION-THERAPY; BIOLOGICAL EFFECTIVENESS; RISK-FACTORS; NECROSIS; PROTON; JAPAN; MULTICENTER; IRRADIATION;
D O I
10.1016/j.radonc.2021.10.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: We aimed to determine the risk factors for radiation-induced brain injury (RIBI1) after carbon ion radiotherapy (CIRT) to predict their probabilities in long-term survivors. Materials and methods: We evaluated 104 patients with head, neck, and skull base tumors who underwent CIRT in a regimen of 32 fractions and were followed up for at least 24 months. RIBI was assessed using the Common Terminology Criteria for Adverse Events. Results: The median follow-up period was 45.5 months; 19 (18.3 %) patients developed grade >= 2 RIBI. The maximal absolute dose covering 5 mL of the brain (D5ml) was the only significant risk factor for grade >2 RIBI in the multivariate logistic regression analysis (p = 0.001). The tolerance doses of D5ml for the 5% and 50% probabilities of developing grade >= 2 RIBI were estimated to be 55.4 Gy (relative biological effectiveness [RBE]) and 68.4 Gy (RBE) by a logistic model, respectively. Conclusion: D5ml was most significantly associated with grade >= 2 RIBI and may enable the prediction of its probability. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 50 条
  • [41] Tobacco use among long-term survivors of head and neck cancer treated with radiation therapy
    Chen, Allen M.
    Vazquez, Esther
    Courquin, Jean
    Donald, Paul J.
    Farwell, D. Gregory
    PSYCHO-ONCOLOGY, 2014, 23 (02) : 190 - 194
  • [42] Adjuvant Therapy with Immune Checkpoint Inhibitors after Carbon Ion Radiotherapy for Mucosal Melanoma of the Head and Neck: A Case-Control Study
    Mizoguchi, Nobutaka
    Kano, Kio
    Okuda, Tatsuya
    Koge, Hiroaki
    Shima, Satoshi
    Tsuchida, Keisuke
    Takakusagi, Yosuke
    Kawashiro, Shohei
    Yoshida, Manatsu
    Kitani, Yuka
    Hashimoto, Kaori
    Furukawa, Madoka
    Shirai, Katsuyuki
    Kamada, Tadashi
    Yoshida, Daisaku
    Katoh, Hiroyuki
    CANCERS, 2024, 16 (15)
  • [43] Long-term Outcomes of Fractionated Stereotactic Radiotherapy for Intracranial Skull Base Benign Meningiomas in Single Institution
    Onodera, Shunsuke
    Aoyama, Hidefumi
    Katoh, Norio
    Taguchi, Hiroshi
    Yasuda, Kouichi
    Yoshida, Daisuke
    Surtherland, Ken
    Suzuki, Ryusuke
    Ishikawa, Masayori
    Gerard, Bengua
    Terasaka, Shunsuke
    Shirato, Hiroki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (04) : 462 - 468
  • [44] Long-term Neurologic Outcomes After Traumatic Brain Injury
    Bazarian, Jeffrey J.
    Cernak, Ibolja
    Noble-Haeusslein, Linda
    Potolicchio, Samuel
    Temkin, Nancy
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2009, 24 (06) : 439 - 451
  • [45] Dose-volume histogram analysis of brainstem necrosis in head and neck tumors treated using carbon-ion radiotherapy
    Shirai, Katsuyuki
    Fukata, Kyohei
    Adachi, Akiko
    Saitoh, Jun-ichi
    Musha, Atsushi
    Abe, Takanori
    Kanai, Tatsuaki
    Kobayashi, Daijiro
    Shigeta, Yuka
    Yokoo, Satoshi
    Chikamatsu, Kazuaki
    Ohno, Tatsuya
    Nakano, Takashi
    RADIOTHERAPY AND ONCOLOGY, 2017, 125 (01) : 36 - 40
  • [46] Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life
    Gupta, Priyamvada
    Jalali, Rakesh
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (12)
  • [47] Radiation-induced Parotid Gland Atrophy in Patients with Head and Neck Cancer After Carbon-ion Radiotherapy
    Morikawa, Takamichi
    Koto, Masashi
    Hasegawa, Azusa
    Takagi, Ryo
    Fujikawa, Akira
    Tsuji, Hiroshi
    Shibahara, Takahiko
    Kamada, Tadashi
    ANTICANCER RESEARCH, 2016, 36 (10) : 5403 - 5407
  • [48] Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers
    Engeseth, Grete May
    Stieb, Sonja
    Mohamed, Abdallah Sherif Radwan
    He, Renjie
    Stokkevag, Camilla Hanquist
    Brydoy, Marianne
    Fuller, Clifton Dave
    Garden, Adam S.
    Rosenthal, David, I
    Phan, Jack
    Morrison, William H.
    Reddy, Jay P.
    Wu, Richard
    Zhang, Xiaodong
    Frank, Steven Jay
    Gunn, Gary Brandon
    RADIOTHERAPY AND ONCOLOGY, 2020, 151 : 119 - 125
  • [49] Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy
    Child, Amanda E.
    Warren, Emily A.
    Grosshans, David R.
    Paulino, Arnold C.
    Okcu, M. Fatih
    Ris, M. Douglas
    Mahajan, Anita
    Orobio, Jessica
    Cirino, Paul T.
    Minard, Charles G.
    Viana, Andres G.
    Bick, Johanna
    Woods, Steven P.
    Chintagumpala, Murali
    Kahalley, Lisa S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [50] Long-term outcomes of grade I/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy
    Hasegawa, Hirotaka
    Vakharia, Kunal
    Graffeo, Christopher S.
    Carlson, Matthew L.
    Pollock, Bruce E.
    Brown, Paul D.
    Perry, Avital
    Van Gompel, Jamie J.
    Driscoll, Colin L. W.
    Link, Michael J.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (02) : 273 - 281